Platelet Disorders and Thrombocytopenia

Platelet disorders and thrombocytopenia is the area of hematopathology concerned with abnormalities in the number or function of platelets, the small anucleate blood cells that initiate hemostasis. It spans the laboratory measurement of platelet count and morphology, the immune and drug-related causes of a falling platelet count, and the inherited and acquired defects that impair platelet function even when the count is normal.

Definition

Platelet disorders and thrombocytopenia denote the spectrum of conditions in which platelets are reduced in number (thrombocytopenia) or impaired in function, studied through laboratory evaluation of the platelet count, platelet morphology, and platelet function within hematopathology.

Scope

The area orients readers to how platelet quantity and quality are assessed and interpreted in the laboratory, and to the principal disease groups that present as thrombocytopenia or as a platelet-function defect. It covers platelet enumeration and morphology, immune thrombocytopenia and alloimmune platelet refractoriness, platelet function disorders and their testing, and drug-induced thrombocytopenia including heparin-induced thrombocytopenia. It is a reference and educational overview of laboratory hematology and is not a source of diagnostic thresholds or treatment instructions for individual patients.

Sub-topics

• Drug-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia (HIT)
• Immune Thrombocytopenia (ITP) and Alloimmunized Platelet Refractoriness
• Platelet Enumeration and Morphological Assessment
• Platelet Function Disorders and Platelet-Function Testing

Core questions

• Is a low platelet count real or an artifact of specimen collection?
• Does a bleeding tendency reflect too few platelets, dysfunctional platelets, or another hemostatic defect?
• Is the thrombocytopenia caused by reduced production, increased destruction, or sequestration?
• When is thrombocytopenia immune, drug-related, or part of a prothrombotic syndrome such as heparin-induced thrombocytopenia?

Key concepts

• Platelet count and the distinction between true thrombocytopenia and pseudothrombocytopenia
• Reduced production versus increased destruction versus sequestration
• Immune-mediated platelet destruction
• Platelet function defects with a normal platelet count
• Heparin-induced thrombocytopenia as a prothrombotic, immune drug reaction
• Platelet refractoriness after transfusion

Mechanisms

Thrombocytopenia arises through three broad routes: decreased marrow production, increased peripheral destruction or consumption, and splenic sequestration. Immune mechanisms underlie much of the destruction, as in immune thrombocytopenia and in drug-induced immune thrombocytopenia, where antibodies target platelet glycoproteins. Heparin-induced thrombocytopenia is mechanistically distinct, driven by antibodies to platelet factor 4 bound to heparin that activate platelets and produce a paradoxical thrombotic state (Greinacher, 2015). Separately, platelets may be present in normal numbers but fail to adhere, aggregate, or secrete normally, producing a functional bleeding tendency that count alone cannot detect (Harrison et al., 2011).

Clinical relevance

Distinguishing the cause of a low or dysfunctional platelet picture underlies the laboratory evaluation of bleeding and bruising and informs the recognition of conditions such as immune thrombocytopenia and heparin-induced thrombocytopenia (Cooper & Ghanima, 2019). This area describes how platelet abnormalities are detected and classified in the laboratory; it is educational and does not provide diagnostic cut-offs or management recommendations for individual patients.

Epidemiology

Thrombocytopenia is among the most common hematologic abnormalities encountered in laboratory practice, arising in settings ranging from primary immune thrombocytopenia to drug exposure, infection, liver disease, and critical illness. Detailed incidence figures vary by cause and population and are addressed in the individual topic entries.

History

Recognition of platelets as discrete blood elements with a hemostatic role developed in the late nineteenth century, and quantitative platelet counting became routine with automated hematology analyzers in the twentieth century. The understanding of immune destruction, the standardization of terminology for immune thrombocytopenia, and the elucidation of the platelet factor 4-heparin antibody mechanism of heparin-induced thrombocytopenia mark major steps in defining the field (Greinacher, 2015).

Seminal works

• greinacher-2015
• cooper-2019
• harrison-2011

Frequently asked questions

What is the difference between thrombocytopenia and a platelet function disorder?

Thrombocytopenia means the platelet count is low, whereas a platelet function disorder means platelets are present in adequate numbers but do not work normally. Both can cause bleeding, and the laboratory evaluation differs because a count alone does not reveal a functional defect.

Can a low platelet count be a laboratory artifact?

Yes. Pseudothrombocytopenia, most often caused by EDTA-dependent platelet clumping in the collection tube, can give a falsely low automated count; examination of the blood film and a repeat sample help distinguish it from true thrombocytopenia.